Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol for Secondary Brain Injury in Concussed Boxers
NCT01321151Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Mar 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in concussion (mTBI) comparing Resveratrol Arm with Placebo Arm (2 arms). Primary endpoint: Aspartate Transaminase/Alanine Transaminase Ratio at 7 days. Started Mar 2011; status: completed.
02
Drugs
resveratrol
03
Conditions
concussion (mTBI)
Beyond the preview
Go deeper on NCT01321151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01321151.